digestive/alimentary system
• at 6-8 months of age, 83% of mice show symptoms of neoplasia (rectal bleeding, anemia, splenomegaly) and 1 or more macroadenomas in the intestinal tract relative to 56% in Apctm1Cip heterozygotes
• a greater % of mice develop 51 to 100 or over 100 polyps (all sizes) in the intestinal tract, and the average number of tumors per mouse is ~3-fold higher than that in Apctm1Cip heterozygotes
|
neoplasm
• at 6-8 months of age, 83% of mice show symptoms of neoplasia (rectal bleeding, anemia, splenomegaly) and 1 or more macroadenomas in the intestinal tract relative to 56% in Apctm1Cip heterozygotes
• a greater % of mice develop 51 to 100 or over 100 polyps (all sizes) in the intestinal tract, and the average number of tumors per mouse is ~3-fold higher than that in Apctm1Cip heterozygotes
|
• mice develop more tumors, esp. larger ones, in the intestinal tract; the average number of macroadenomas (>5 mm) per mouse is ~3-fold higher than that in Apctm1Cip heterozygotes
• however, no differences in tumor grade, aggressiveness or proliferation are observed
|